Inhibitors of the interaction between MDM2 and p53

Details for Australian Patent Application No. 2008300527 (hide)

Owner Janssen Pharmaceutica NV

Inventors Coupa, Sophie; Storck, Pierre-Henri; Poncelet, Virginie Sophie; Schoentjes, Bruno

Agent Shelston IP

Pub. Number AU-A-2008300527

PCT Pub. Number WO2009/037308

Priority 07116889.2 21.09.07 EP

Filing date 18 September 2008

Wipo publication date 26 March 2009

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4045 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

29 April 2010 PCT application entered the National Phase

  PCT publication WO2009/037308 Priority application(s): WO2009/037308

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008300528-Cool artificial turf

2008300526-Accelerated reduction of organic substances with boranes